Thermophilic glucose isomerase mutant and application thereof

Through genetic engineering of the thermophilic glucose isomerase mutant D343K, the problem of poor thermal stability of existing enzymes under high temperature conditions is solved, and efficient catalytic activity at 70 ℃ and 80 ℃ is achieved, filling the market's high-temperature resistant enzymes The gap provides an efficient solution for the industrial production of HFCS-55.

CN118931891APending Publication Date: 2024-11-12TIANJIN UNIV OF SCI & TECH
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411419558.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-12
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing glucose isomerase has poor thermal stability under high temperature conditions, resulting in low industrial production efficiency of HFCS-55 and is difficult to meet industrial needs.

Method used

Through genetic engineering and enzyme engineering technology, a thermophilic glucose isomerase mutant D343K was designed and obtained. Its amino acid sequence replaced aspartic acid with lysine through site-directed mutation, improving the thermal stability and catalytic activity of the enzyme .

Benefits of technology

Thermophilic glucose isomerase mutant D343K has significantly improved the half-life at 70 °C and 80 °C, catalyzing the conversion rate of 5 M D-glucose to 56%, filling the market's shortcomings of high-temperature enzymes and has the industrial production of HFCS-55. potential.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The invention provides a thermophilic glucose isomerase mutant and application thereof. Glucose isomerase of a strain Fervidobacterium godwanense is used as a parent, and site-directed mutagenesis is carried out on amino acid residues at key sites of the parent, so that the thermophilic glucose isomerase mutant D343K is obtained. Compared with previously reported enzymes, the thermophilic mutant D343K of glucose isomerase provided by the invention has more excellent catalytic activity and thermal stability, the relative enzyme activity of the mutant D343K is 190% of that of a wild type, the half-life period (t1 / 2) value at 70 DEG C is increased to 10 h from 5 h, and the half-life period (t1 / 2) value at 80 DEG C of the mutant D343K is increased to 45 min from 15 min of the wild type. The thermophilic mutant D343K shows excellent catalytic activity and thermal stability at 80 DEG C, can overcome the defect of high-temperature-resistant enzyme in the market, and can be used for industrial production of HFCS-55.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of gene engineering and enzyme engineering, and specifically relates to a mutant of thermophilic glucose isomerase and application thereof. Background Art

[0002] High fructose corn syrup (HFCS) is mainly composed of D-glucose and D-fructose. It is widely used in the pharmaceutical and chemical industries because of its superior properties such as sweetness without being greasy, refreshing and delicious, and good moisture absorption and moisture retention. It is a commonly used sweetener for beverages, canned foods, dairy products, ice cream, health products, etc. HFCS can be divided into three types according to the proportion of D-fructose: HFCS-42, HFCS-55 and HFCS-90. HFCS-42 has a low D-fructose content, and its application in medical and health care is limited. In addition, D-glucose will precipitate due to saturated crystals during low-temperature storage and transportation, affecting transportation and use. In contrast, HFCS-55, which has a high D-fructose content, is relatively stable at low temperatures and is not easy to crystallize, is the current mainstream product. HFCS-55 is mainly obtained by blending HFCS-42 and HFCS-90, and HFCS-90 is obtained by separating, purifying and concentrating HFCS-42. By synthesizing HFCS-55 in one step, the traditional production process of HFCS-42 chromatographic purification to prepare HFCS-90 can be skipped, which will significantly reduce its production cost. At present, the preparation of HFCS-55 is mainly chemical synthesis and biosynthesis. The chemical method has a violent reaction process, and is prone to Maillard reaction, resulting in many by-products and pigment residues. The separation is complex and is not suitable for industrial production. The bioenzymatic synthesis reaction conditions are mild and the specificity is strong, which will become the mainstream method for the industrial production of HFCS-55.

[0003] Glucose isomerase (GI, EC 5.3.1.5), also known as xylose isomerase (XI), can isomerize D-glucose or D-xylose into D-fructose or D-xylulose. The isomerization of D-glucose into D-fructose is an endothermic reaction, which is at an energy disadvantage and is not conducive to the reaction flow in the direction of D-fructose. Therefore, high temperature conditions are required in the industrial production of HFCS-55 to promote the reaction in the direction of D-fructose production to meet the requirements of industrial production. At present, most commercial enzymes (derived from Bacillus, Actinomycetes, Streptomyces, etc.) have poor thermal stability. When reacting at above 80°C, the enzyme preparation is easily inactivated, and the conversion rate is as high as 42-45%, which is difficult to meet the requirements of one-step synthesis of HFCS-55 by biological method. In view of this, the present invention utilizes genetic engineering and enzyme engineering to obtain a high temperature resistant enzyme preparation, in order to improve the production efficiency of HFCS-55 under high temperature conditions, and fill the shortage of high temperature resistant glucose isomerase on the market. Summary of the invention

[0004] The purpose of the present invention is: 1) to obtain a mutant of thermophilic glucose isomerase by using genetic engineering and enzyme engineering; 2) to provide a recombinant vector or host bacteria expressing the thermophilic glucose isomerase mutant; 3) to provide the application of the thermophilic glucose isomerase mutant.

[0005] To achieve the above object, the present invention provides a mutant D343K of thermophilic glucose isomerase, the amino acid sequence of which is shown in SEQ ID NO: 1, Fervidobacterium gondwanense The amino acid sequence encoding glucose isomerase (GenBank: AAR07504.1) was used as the parent, and the amino acid residue at position 343 of its active catalytic center was mutated from aspartic acid to lysine by site-directed mutagenesis.

[0006] Furthermore, the present invention provides a gene sequence encoding the thermophilic glucose isomerase mutant, as shown in SEQ ID NO: 2. The specific sequence is as follows: SEQ ID NO: 1 MYFNVEKVVYEGPSSKNLLAYKFYNPEEEIAGKKMRDWFRFAVAYWHTFNSRGEDPFGSATFERPWFKKDPMDTAFAKVDALFEFCEKTGVEYFTFHDRDLAHEGLTL RESNKILDKVVEKIKEYMKSSNVKLLWGTANLFSHPRYAQGAATSPNPLVFSYAASQVKKMLDVTKELGGLGYVLWGGREGYDNLLLTDSALEEKLFARFLEMVVEYK ERIGFNGVLMIEPKPKEPTKHQYDFDASTVLYFLKKHNLFEHFKLNIEANHATLAGHTFAHELRVARLNGKLGSIDANRGDLLLGWDTDQFPTDVYETTFAMYEVLEN NGLDCGFNFDAKVRRASIKPEDIVYAHVSSMDAFALGLKLAVKLREKVKPMIEERYSEYNSEIGMKILEGKTTLDELSSYVEDLTDVRVKSLKQELLEMVINDVIFGGR SEQ ID NO: 2 The present invention also provides an expression vector carrying a DNA sequence encoding the above-mentioned thermophilic glucose isomerase mutant; preferably, the recombinant vector includes but is not limited to: Escherichia coli expression vector pET series, pQE series, pMAL series, Pichia pastoris expression vector pPIC9k; further, the present invention provides a recombinant strain, the recombinant strain contains the above-mentioned recombinant expression vector; preferably, the recombinant strain of the expression vector is: E. coli BL21(DE3), Bacillus subtilis, Pichia pastoris, Saccharomyces cerevisiae.

[0007] The present invention also provides the use of the above-mentioned recombinant vector or recombinant strain, especially the use in thermophilic glucose isomerase mutant. Experimental results show that the half-life (t 1 / 2 ) value is 10 h, and the half-life (t 1 / 2 ) value was 45 min, indicating excellent thermal stability. The thermophilic glucose isomerase mutant D343K catalyzed 5 M D-glucose with a conversion rate of 56% in 60 min, which has the potential for industrial production of HFCS-55.

[0008] Furthermore, the application of the thermophilic glucose isomerase mutant provided by the present invention is specifically that the thermophilic glucose isomerase mutant of the present invention isomerizes D-glucose into D-fructose.

[0009] Furthermore, the application is for preparing high fructose syrup, wherein the feature is that the fructose content of the high fructose syrup is not less than 55%.

[0010] The positive effects of the thermophilic glucose isomerase mutant and its application disclosed in the present invention are: The thermophilic mutant D343K of glucose isomerase provided by the present invention has excellent catalytic activity and thermal stability. Compared with the wild type, the relative enzyme activity of the mutant D343K is 190% of that of the wild type, and the half-life (t 1 / 2 ) value increased from 5 h to 10 h, and its half-life (t 1 / 2 ) value increased from 15 min to 45 min. The results showed that the thermophilic mutant D343K of glucose isomerase could fill the shortage of thermostable enzymes in the market and could be used for the industrial production of HFCS-55. BRIEF DESCRIPTION OF THE DRAWINGS

[0011] Figure 1 Comparison of relative enzyme activities of the wild type WT and mutant D343K of the present invention at 80°C; Figure 2Comparison of the thermal stability of the wild type WT and mutant D343K of the present invention at 70°C; Figure 3 Comparison of the thermal stability of the wild type WT and mutant D343K of the present invention at 80°C; Figure 4 The conversion rates of the wild type WT and mutant D343K of the present invention at 80°C were compared. DETAILED DESCRIPTION

[0012] The following is a further description of the present invention in conjunction with specific examples, but the scope of the present invention is not limited thereto, and the essence and scope of the present invention are only limited by the claims. For those skilled in the art, various adjustments or modifications to the material components and dosages in these embodiments are also within the scope of the present invention without departing from the essence and scope of the present invention.

[0013] In the specific implementation of the present invention, the mutants obtained are defined as follows: The identification (naming) principle of mutants: the mutant obtained by the substitution (mutation) is represented by "original amino acid residue + residue position + replaced amino acid residue" in the amino acid sequence. For example, "D343K" is used to represent a mutant obtained by replacing the 343rd amino acid residue in the amino acid sequence with lysine from aspartic acid of the parent WT.

[0014] Definition of glucose isomerase activity: Under standard conditions for enzyme activity determination, the amount of glucose isomerase required to produce 1 μmol D-fructose per minute is defined as one enzyme activity unit, expressed as U.

[0015] Definition of relative enzyme activity: The enzyme activity of the wild-type glucose isomerase measured is defined as 100%, and the enzyme activity of the mutant is measured and calculated based on this standard.

[0016] The GI enzyme activity determination method refers to the national standard method, and then the improved method is performed according to the materials of the present invention, as follows: 0.5 M D-glucose, 1 mM Co 2+ , 10 mM Mg 2+ and 10 μM glucose isomerase in 1 mL PBS buffer (pH 7.3), react at 80 °C for 5 min, terminate the reaction in an ice-water bath, and centrifuge the reaction product to detect the D-fructose concentration using the BC2450-50T / 48S plant tissue fructose (FT) content detection kit.

[0017] (1) Construction of recombinant vector pET-22b(+)-WT according to Fervidobacterium gondwanenseThe wild-type WT amino acid sequence (GenBank: AAR07504.1) was used to synthesize its gene sequence and ligated to the restriction site of the E. coli expression vector pET-22b(+). N I and XOt I, a recombinant vector pET-22b(+)-WT containing the wild-type glucose isomerase gene was obtained.

[0018] The pET-22b(+) vector in this step can also be replaced by pQE series, pMAL series and pPIC9K vectors.

[0019] (2) Construction of mutation expression vector Using the recombinant plasmid pET-22b(+)-WT obtained in step (1) as a template, the site-directed mutagenesis primers D343K-F and D343K-R (as shown in Table 1) were designed and a site-directed mutagenesis PCR amplification reaction was performed to construct a mutant expression vector.

[0020] Mutation Primers D343K-F: ATCAAACCGGAAGATATCGTTTACGCGCATGTTTC D343K-R: GCTTGCACGGCGTACTTTAGCATCAAAGTTGAAAC PCR amplification: The target gene of pET-22b(+)-WT was site-directed mutagenesis using the KOD-Plus mutant kit (purchased from Toyobo (Shanghai) Biotechnology Co., Ltd.). The total volume of the reaction system was 25 μL. The components of the reaction system are shown in Table 1.

[0021] Table 1 PCR amplification reaction system Components Addition volume (μL) KOD-plus polymerase 0.5 Buffer (KOD buffer) 2.5 D343K-F(10 μM) 0.75 D343K-R(10 μM) 0.75 pET-22b(+)-WT recombinant plasmid (50 ng / L) 1 <![CDATA[Sterile water (ddH2O)]]> 17 The PCR reaction procedure was as follows: 94°C pre-denaturation for 2 min; 98°C denaturation for 10 s; 68°C extension for 7 min; after 7 cycles, store at 4°C; after the reaction, take 2 uL of the PCR product for agarose gel electrophoresis band verification. Add 0.4 μL of Dpn I enzyme (to eliminate the original template) was added, and the digestion reaction was carried out at 37 °C for 1 h. After the digestion reaction, the gene fragments of the digestion products were enzymatically ligated. The total volume of the enzymatic ligation system was 15 μL, and the components were shown in Table 2.

[0022] Table 2 Enzymatic ligation reaction system Components Addition volume (μL) Enzyme digestion products 3 Ligation high 5 T4 Polynucletide Kinase 1 <![CDATA[Sterile water (ddH2O)]]> 6 The above enzymatic system was gently mixed, centrifuged, and then reacted at 16°C for 1 h.

[0023] After the reaction was completed, a trace amount (10 μL) of the cyclized product was transformed into Escherichia coli by thermal stimulation. E. coliJM109 competent cells. The transformed competent cells were added to an LB plate containing ampicillin resistance (100 μg / mL), the cells were evenly spread, and inverted and cultured at 37 ° C overnight. Then the grown transformants were picked, and the positive clones were subjected to plasmid extraction and DNA sequencing. The individuals with correct sequencing were successfully constructed mutant expression vectors. The present invention obtains the pET-22b (+) -D343K mutant expression vector through the above steps.

[0024] (3) Inducible expression of mutant enzymes The successfully sequenced plasmid was transformed into Escherichia coli by heat shock method. E. coli BL21(DE3) cells were cultured, positive transformants were selected and placed in 5 mL LB medium containing 100 μg / mL ampicillin resistance, and cultured at 37°C and 220 r / min for 6-8 h to obtain seed solution; the seed solution was inoculated into 400 mL LB medium at a volume ratio of 3% and cultured at 37°C and 220 r / min until OD 600 The value was 0.7-0.8, then the temperature was lowered to 16 °C, IPTG with a final concentration of 0.5 mM was added and induced at 16 °C and 120 r / min for 16-18 h to obtain the fermentation broth.

[0025] The two fermentation broths were centrifuged at 4 °C and 8000 r / min for 10 min, respectively, and the wet cells were collected; after resuspending with solution A (20 mM Tris-HCl, pH 7.3, 500 mM NaCl, 20 mM imidazole, 2 mM DTT), lysozyme (final concentration was 200 μg / mL) and PMSF (final concentration was 0.5 mM) were added and placed on ice for 15 min, and then ultrasonically disrupted on ice (2 s, 4 s interval, power 240 W), followed by low-temperature high-speed centrifugation (4 °C, 12000 r / min) to collect the supernatant liquid.

[0026] The two supernatants were purified by nickel column (Ni-NTA) affinity chromatography: 2 open columns were taken, and 1 mL Ni-NTA resin (QIAGEN) was added to each column; the resin (QIAGEN) was equilibrated with 5 column volumes of solution A, and then the supernatant was combined with 1 mL of resin at 4 °C for 50 min; the mixed solution was passed through the open column, and the His-tagged protein was retained by the resin; then the resin was rinsed with 1 column volume of solution A; finally, the target protein was eluted with 1 column volume of solution B (20 mM Tris-HCl, pH 7.3, 300 mM NaCl, 400 mM imidazole, 2 mM DTT). The eluted target protein was replaced with 1× PBS buffer (pH 7.3) using an ultrafiltration tube, and the obtained two proteins were stored in a refrigerator at 4 °C for future use. The two proteins include: wild-type WT (parent) and mutant D343K.

[0027] (1) Determination of relative enzyme activity between wild type WT and mutant D343K 0.5 M D-glucose, 1 mM Co 2+ , 10 mM Mg 2+ and 10 μM glucose isomerase in 1 mL PBS buffer (pH 7.3), reacted at 80 °C for 5 min, and terminated the reaction in an ice water bath. The relative enzyme activity of the mutant was 100% of the wild-type enzyme activity. The relative enzyme activity of the purified wild-type WT and mutant D343K was determined according to the method of Example 1. The results are as follows: Figure 1 As shown, the relative enzyme activity of mutant D343K is 190% of that of the wild type ( Figure 1 As shown in Figure 3, mutant D343K greatly improved the catalytic activity towards D-glucose.

[0028] (2) Thermal stability determination of wild type WT and mutant D343K The purified wild-type WT and mutant D343K were incubated at 70°C and samples were taken at intervals (1, 2, 3, 4, 6, 8, 10, 12, 14 and 16 h) to determine the residual enzyme activity; the purified wild-type WT and mutant D343K were incubated at 80°C and samples were taken at intervals (5, 10, 15, 20, 25, 30, 35, 40, 45 and 50 min) to determine the residual enzyme activity. The enzyme activity at 0 h, i.e., without incubation, was defined as 100%. The relative enzyme activities of the purified wild-type and mutant D343K were determined by referring to the method in Example 1 above, and the half-lives (t 1 / 2 The half-life (t 1 / 2 ) was significantly higher than the wild type. Figure 2 and 3The half-life of mutant D343K at 70 °C (t 1 / 2 ) value increased from 5h to 10 h, which is 200% of the wild type. The half-life (t 1 / 2 ) value increased from 15 min to 45 min, which is 300% of the wild type, indicating that the thermophilic glucose isomerase mutant D343K obtained in the present invention has enhanced thermal stability.

[0029] 5 M D-glucose, 1 mM Co 2+ , 10 mM Mg 2+ and 100 μM glucose isomerase in 200 mL PBS buffer (pH 7.3), reacted at 80 °C and 150 r / min, and sampled at intervals. Finally, the reaction was terminated in an ice-water bath, and the D-fructose concentration was detected by the BC2450-50T / 48S plant tissue fructose (FT) content detection kit. The yield of D-fructose generated by D-glucose isomerization reaction of wild type WT and mutant D343K at different reaction times is shown in Figure 2. Figure 4 As shown, after 60 minutes of reaction, the substrate conversion rate of the wild-type WT was close to 43%, and the substrate conversion rate of the mutant D343K was as high as 56%. The catalytic activity of the mutant D343K was 130% of that of the wild-type WT, and it has the application value of industrial production of HFCS-55.

Claims

1. A thermophilic mutant D343K of glucose isomerase, whose amino acid sequence is shown in SEQ ID NO:

1.

2. The gene sequence encoding the thermophilic glucose isomerase mutant according to claim 1, wherein the gene sequence is shown in SEQ ID NO:

2.

3. The recombinant vector or recombinant strain encoding the thermophilic glucose isomerase mutant gene according to claim 2.

4. The recombinant vector or recombinant strain according to claim 3, characterized in that: The recombinant vectors include but are not limited to: Escherichia coli expression vectors pET series, pQE series, pMAL series, Pichia pastoris expression vector pPIC9k; the recombinant strains of the expression vectors are: E. coli BL21 (DE3), Bacillus subtilis, Pichia pastoris, Saccharomyces cerevisiae.

5. Use of the thermophilic glucose isomerase mutant according to claim 1 for isomerizing D-glucose into D-fructose; wherein the use is for preparing high fructose syrup.

6. The use according to claim 5, characterized in that the content of D-fructose in the high fructose syrup is not less than 55%2.

Citation Information

Cited By

  • Aldose isomerase mutant and application thereof

    CN122427908A

  • Aldehyde sugar isomerase mutant and use thereof

    CN122427908B